在纳入血液透析患者的试验中测量生活质量:使用肾脏疾病生活质量问卷的方法学问题
该系统综述检索电子数据库,纳入61项使用肾脏疾病生活质量问卷(KDQoL)任何版本测量血液透析患者生活质量的试验。82%的试验报告了脱落,7%采用插补法、72%采用完整病例分析处理缺失数据,仅7%进行敏感性分析。70%的文章修改了已验证问卷或仅报告有统计学显著性的结果,缺失数据处理未依据缺失机制,可能引入偏倚。
要点
- 82%的试验报告了脱落,但仅7%进行敏感性分析评估缺失数据的影响。
- 72%的试验采用完整病例分析,7%采用插补法处理脱落导致的缺失数据。
- 70%的文章修改了已验证的KDQoL问卷或仅报告有统计学显著性的结果。
核心结论
- 缺失数据未依据缺失数据机制处理,可能导致偏倚。
- 患者报告结局指标使用的不一致性使这些试验的有效性受到质疑。
- 肾脏病试验中的方法学问题可能是改善该患者群体生活质量的有效干预措施有限的一个促进因素。
研究设计与样本
- 系统检索电子数据库,纳入使用肾脏疾病生活质量问卷(KDQoL)任何变体测量血液透析患者生活质量的试验。
- 综述在Covidence版本2中进行,定量分析在Stata版本16中进行。
- 共纳入61项试验,其中82%报告了脱落。
主要发现
- 处理脱落所致缺失数据的方法包括插补法(7%)和完整病例分析(72%)。
- 少数试验(7%)进行敏感性分析以评估缺失数据对研究结果的影响。
- 使用了单一插补技术,但仅在关于缺失类型和模式的强假设下有效。
- KDQoL报告存在不一致性,许多文章(70%)修改了已验证问卷或仅报告有统计学显著性的结果。
关键数值与推荐
- 处理脱落所致缺失数据的方法:插补法7%,完整病例分析72%。
- 进行敏感性分析以评估缺失数据影响的试验占7%。
- 修改已验证问卷或仅报告有统计学显著性结果的文章占70%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Haemodialysis (HD) treatment causes a significant decrease in quality of life (QoL). When enrolled in a clinical trial, some patients are lost prior to follow-up because they die or they receive a kidney transplant. It is unclear how these patients are dealt with in the analysis of QoL data. There are questions surrounding the consistency of how QoL measures are used, reported and analysed. METHODS: A systematic search of electronic databases for trials measuring QoL in HD patients using any variation of the Kidney Disease Quality of Life (KDQoL) Questionnaire was conducted. The review was conducted in Covidence version 2. Quantitative analysis was conducted in Stata version 16. RESULTS: We included 61 trials in the review, of which 82% reported dropouts. The methods to account for missing data due to dropouts include imputation (7%) and complete case analysis (72%). Few trials (7%) conducted a sensitivity analysis to assess the impact of missing data on the study results. Single imputation techniques were used, but are only valid under strong assumptions regarding the type and pattern of missingness. There was inconsistency in the reporting of the KDQoL, with many articles (70%) amending the validated questionnaires or reporting only statistically significant results. CONCLUSIONS: Missing data are not dealt with according to the missing data mechanism, which may lead to biased results. Inconsistency in the use of patient-reported outcome measures raises questions about the validity of these trials. Methodological issues in nephrology trials could be a contributing factor to why there are limited effective interventions to improve QoL in this patient group. PROSPERO REGISTRATION: CRD42020223869.
引用
- Worboys HM, Cooper NJ, Burton JO, et al. Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire. Nephrol Dial Transplant. 2022. PMID: 35689670. doi:10.1093/ndt/gfac170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。